van den Brink, Wim <br/><br/>
Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme.  [electronic resource] 

 -  Expert opinion on drug safety  Apr 2015 
 - 495-504 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-764X 
<br/><br/><label>Standard No.: </label>10.1517/14740338.2015.1011619  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alcohol Drinking--prevention & control<br/>Alcoholism--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Naltrexone--administration & dosage<br/>Narcotic Antagonists--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Treatment Outcome